Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging

NCT06827678 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT06827678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06827678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging
Lead sponsor
Huashan Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2022
Completion date
July 30, 2027
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, positron emission tomography